120 related articles for article (PubMed ID: 10686660)
1. Amlodipine and physiological responses to brisk exercise in healthy subjects.
Stankovic S; Panz V; Klug E; Di Nicola G; Joffe BI
Cardiovasc Drugs Ther; 1999 Nov; 13(6):513-7. PubMed ID: 10686660
[TBL] [Abstract][Full Text] [Related]
2. Perindopril and physiologic responses to exercise.
Klug EQ; Joffe BI; Panz VR; Meyer TE; Fine BJ; Seftel HC
J Cardiovasc Pharmacol; 1994 Jun; 23(6):864-8. PubMed ID: 7523776
[TBL] [Abstract][Full Text] [Related]
3. Effect of calcium antagonists on stress-induced rise in blood pressure and heart rate: a double-blind, placebo-controlled study.
Malhotra S; Kumari S; Pandhi P
Int J Clin Pharmacol Ther; 2001 Jan; 39(1):19-24. PubMed ID: 11204933
[TBL] [Abstract][Full Text] [Related]
4. Divergent effects of verapamil and amlodipine at rest and during exercise.
Joannides R; Moore N; Iacob M; Compagnon P; Bacri AM; Thuillez C
J Hypertens Suppl; 1998 Jan; 16(1):S25-9. PubMed ID: 9534093
[TBL] [Abstract][Full Text] [Related]
5. A new Ca-antagonist, azelnidipine, reduced blood pressure during exercise without augmentation of sympathetic nervous system in essential hypertension: a randomized, double-blind, placebo-controlled trial.
Arita M; Hashizume T; Tanigawa K; Yamamoto H; Nishio I
J Cardiovasc Pharmacol; 1999 Feb; 33(2):186-92. PubMed ID: 10028925
[TBL] [Abstract][Full Text] [Related]
6. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study.
Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Fluckiger L; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; van Roon AM; Smit AJ
Am J Hypertens; 2001 Nov; 14(11 Pt 1):1083-9. PubMed ID: 11724204
[TBL] [Abstract][Full Text] [Related]
7. Effect of amlodipine on cardiopulmonary performance in volunteers.
Lay L; Bjorksten AR; Stainsby GV; Blake DW
Clin Exp Pharmacol Physiol; 2001; 28(1-2):25-7. PubMed ID: 11153533
[TBL] [Abstract][Full Text] [Related]
8. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
Sakata K; Shirotani M; Yoshida H; Nawada R; Obayashi K; Togi K; Miho N
Hypertension; 1999 Jun; 33(6):1447-52. PubMed ID: 10373231
[TBL] [Abstract][Full Text] [Related]
9. Effect of amlodipine and felodipine on sympathetic activity and baroreflex function in normal humans.
Goldsmith SR
Am J Hypertens; 1995 Sep; 8(9):902-8. PubMed ID: 8541005
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers.
Ragueneau I; Sao AB; Démolis JL; Darné B; Funck-Brentano C; Jaillon P
Clin Pharmacol Ther; 2001 Mar; 69(3):122-9. PubMed ID: 11240976
[TBL] [Abstract][Full Text] [Related]
11. Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension.
Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; Smit AJ
Br J Clin Pharmacol; 2001 Dec; 52(6):687-92. PubMed ID: 11736880
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats.
Shokoji T; Fujisawa Y; Kiyomoto H; Rahman M; Sun GP; Fan YY; Kimura S; Kohno M; Abe Y; Nishiyama A
Hypertens Res; 2005 Dec; 28(12):1017-23. PubMed ID: 16671342
[TBL] [Abstract][Full Text] [Related]
13. Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction.
Udelson JE; DeAbate CA; Berk M; Neuberg G; Packer M; Vijay NK; Gorwitt J; Smith WB; Kukin ML; LeJemtel T; Levine TB; Konstam MA
Am Heart J; 2000 Mar; 139(3):503-10. PubMed ID: 10689266
[TBL] [Abstract][Full Text] [Related]
14. Persistence of anti-hypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life.
Leenen FH; Fourney A; Notman G; Tanner J
Br J Clin Pharmacol; 1996 Feb; 41(2):83-8. PubMed ID: 8838433
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
Webb DJ; Freestone S; Allen MJ; Muirhead GJ
Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
[TBL] [Abstract][Full Text] [Related]
16. The effect of amlodipine on respiratory and pulmonary vascular responses to hypoxia in mountaineers.
Watt M; Peacock AJ; Newell J; McDonagh T; Grant S
Eur Respir J; 2000 Mar; 15(3):459-63. PubMed ID: 10759437
[TBL] [Abstract][Full Text] [Related]
17. Sympatho-excitatory responses to once-daily dihydropyridines in young versus older hypertensive patients: amlodipine versus felodipine extended release.
Leenen FH; Coletta E; White R
J Hypertens; 2006 Jan; 24(1):177-84. PubMed ID: 16331116
[TBL] [Abstract][Full Text] [Related]
18. Effects of amlodipine in patients with chronic heart failure.
Walsh JT; Andrews R; Curtis S; Evans A; Cowley AJ
Am Heart J; 1997 Nov; 134(5 Pt 1):872-8. PubMed ID: 9398099
[TBL] [Abstract][Full Text] [Related]
19. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension.
Fogari R; Zoppi A; Corradi L; Preti P; Malalamani GD; Mugellini A
J Hypertens; 2000 Dec; 18(12):1871-5. PubMed ID: 11132613
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension.
Zanchetti A; Omboni S; La Commare P; De Cesaris R; Palatini P
J Cardiovasc Pharmacol; 2001 Oct; 38(4):642-50. PubMed ID: 11588535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
